Transcutaneous Electrical Stimulation (TENS) and Transcutaneous Electrical Modulation Pain Reprocessing (TEMPR)

This policy covers transcutaneous electrical stimulation (TENS) devices — including physician‑prescribed form‑fitting conductive garments and certain FDA‑cleared device‑specific uses (e.g., Cefaly for migraine and select Cala devices for transient/PD-related hand tremor) — for medically necessary pain management. Coverage is limited to refractory chronic pain causing significant functional disruption after ≥3 months of conservative therapy and requires a physician‑monitored TENS trial of at least 30 days demonstrating regular benefit; TEMPR/scrambler therapy and many other indications or non‑cleared devices are considered experimental/investigational, and use is contraindicated with implanted electrical devices, seizure disorders, pregnancy, and generally limited to adults.

"Refractory chronic pain (e."

Sign up to see full coverage criteria, indications, and limitations.